Varicose Veins Treatment Devices Market

The varicose veins treatment devices market exhibits dynamic growth during the forecast period.

The global varicose veins treatment devices market is increasing proficiently, expected to grow at a CAGR of 6.5%. Worldwide, the increasing burden of varicose veins and improved therapeutic treatment options will drive market growth. Around 40 million people in the U.S. suffer from varicose veins. Growing awareness about new sclerotherapy procedures, laser technology, and minimally invasive procedures to overcome the limitations of traditional procedures will increase the demand for advanced devices. Key factors such as increased expansion and acceptance for enzyme replacement therapy in emerging nations, rising geriatric population, and U.S. FDA approvals for varicose veins treatment products will drive the overall market growth on a global scale.

Market Synopsis

Ablation devices are expected to register higher growth by the end of 2027

Advancements in radiofrequency ablation devices with enhanced biocompatibility will drive market growth. In addition, novel applications for endovenous laser therapy among patients as a standard treatment option will drive market growth, e.g., market approval of polidocanol endovenous microfoam (Varithena, BTG). In January 2017, Varithena (polidocanol injectable foam) was approved in the Canadian market for the treatment of incompetent great saphenous veins. Additionally, greater awareness and enhanced therapy launch in the outpatient centers and clinics for various varicose veins and chronic venous insufficiency procedures will boost the market growth in the developed nations, e.g., Venefit™ procedure. Moreover, the new launch of devices and surgical products such as VenaSeal Closure System, Purespume (pipeline), VBOX hybrid, laser instruments, and other injection sclerotherapy products will spur revenue growth in the near future.

Endovenous thermal ablation to witness a significant CAGR

Preference for minimally invasive thermal ablation procedures (radiofrequency or laser therapy) in developed nations shows promising growth. Moreover, advancements in non-thermal ablation, such as Clarivein treatment (ClariVein® infusion catheter), will drive market growth. Furthermore, advancements in microphlebectomy, ultrasound-guided foam sclerotherapy, micro sclerotherapy, high ligation, and stripping will further spur revenue growth during the forecast period. E.g., advancements in new Echotherapy technology (by Theraclion) show progressive growth for varicose veins treatment and venous ulcers. It is a non-invasive ablation therapy delivered by the SONOVEIN® system that allows treatment without chemical injections, catheters, or incisions.

Increased research and development with solid product pipelines in the developed regions

Major players in the varicose veins treatment market are Medtronic plc, biolitec AG, Syneron Medical Ltd., Lumenis Ltd., Energist Group, AngioDynamics, Inc., Vascular Solutions, Inc., Quanta System S.p.A., Eufoton s.r.l., Sciton, Inc., Dornier MedTech GmbH, Miraval, BTG plc, Sciton, Inc., Merz Pharma GmbH & Co. KGaA, Fotona d.o.o., and others. Major players are developing new technology with collective biological solutions, sclerotherapy, laser surgery, endovenous ablation therapy, ambulatory phlebectomy, vein surgery, and others. New product launches, acquisitions, partnerships with hospitals, technology expansion in developing nations, and improved R&D on varicose veins treatment devices will drive market growth during the forecast period.

Historical & Forecast Period

This study report represents an analysis for each segment from 2017 to 2027, considering 2018 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027.

Segmentation Product Type (2017–2027; US$ Mn)

• Ablation Devices
• Venous Closure Products
• Other Surgical Instruments

 Application (2017–2027; US$ Mn)

• Endovenous Ablation (EVLA)
• o Radiofrequency Ablation Devices
• o Laser Ablation Devices
• Sclerotherapy
• Surgical Ligation & Stripping

 End User Segment (2017–2027; US$ Mn)

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

 Geography Segment (2017–2027; US$ Mn)

• North America (the U.S., Rest of North America)
• Europe (U.K., Germany, France, Rest of Europe)
• Asia Pacific (Japan, China, India, Rest of Asia Pacific)
• Rest of the World (the Middle East & Africa, Latin America)

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities better to understand the overall varicose veins treatment devices market. The global report also represents the competitive landscape based on market initiatives and strategies, product portfolio, and business strengths.

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Varicose Vein Treatment Devices (VVTD) Market
2.2. Global VVTD Market, by Product Type, 2018 (US$ Mn)
2.3. Global VVTD Market, by Treatment Type, 2018 (US$ Mn)
2.4. Global VVTD Market, by End-user, 2018 (US$ Mn)
2.5. Global VVTD Market, by Geography, 2018 (US$ Mn)

3. Market Dynamics
3.1. Introduction
3.1.1. Global VVTD Market Value, 2017-2027, (US$ Mn)
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.3. Attractive Investment Proposition, by Geography, 2018
3.4. Market Positioning of Key Players, 2018
3.4.1. Major Strategies Adopted by Key Players

4. Global Varicose Vein Treatment Devices (VVTD) Market, by Product Type , 2017-2027 (US$ Mn)
4.1. Overview
4.2. Ablation Devices
4.2.1. Radiofrequency Ablation Devices
4.2.2. Laser Ablation Devices
4.3. Venous Closure Products
4.4. Other Surgical Instruments

5. Global Varicose Vein Treatment Devices Market, by Treatment Type, 2017-2027 (US$ Mn)
5.1. Overview
5.2. Endovenous Ablation (EVLA)
5.3. Sclerotherapy
5.4. Surgical Ligation & Stripping

6. Global Varicose Vein Treatment Devices Market, by End-user, 2017-2027 (US$ Mn)
6.1. Hospitals
6.2. Specialty Clinics
6.3. Ambulatory Surgical Centers

7. North America Varicose Vein Treatment Devices VVTD Market Analysis, 2017-2027 (US$ Mn)
7.1. Overview
7.1.1. North America VVTD Market Value and Growth, 2017-2027, (US$ Mn)
7.2. North America VVTD Market Value, By Product Type, 2017-2027 (US$ Mn)
7.2.1. Market Analysis
7.3. North America VVTD Market Value, By Treatment Type, 2017-2027 (US$ Mn)
7.3.1. Market Analysis
7.4. North America VVTD Market Value, By End-user, 2017-2027 (US$ Mn)
7.4.1. Market Analysis
7.5. North America VVTD Market Value, By Region/Country, 2017-2027 (US$ Mn)
7.5.1. Market Analysis
7.5.2. U.S.
7.5.3. Rest of North America

8. Europe Varicose Vein Treatment Devices (VVTD) Market Analysis, 2017-2027 (US$ Mn)
8.1. Overview
8.1.1. Europe VVTD Market Value and Growth, 2017-2027, (US$ Mn)
8.2. Europe VVTD Market Value, By Product Type, 2017-2027 (US$ Mn)
8.2.1. Market Analysis
8.3. Europe VVTD Market Value, By Treatment Type, 2017-2027 (US$ Mn)
8.3.1. Market Analysis
8.4. Europe VVTD Market Value, By End-user, 2017-2027 (US$ Mn)
8.4.1. Market Analysis
8.5. Europe VVTD Market Value, By Region/Country, 2017-2027 (US$ Mn)
8.5.1. Market Analysis
8.5.2. U.K.
8.5.3. Germany
8.5.4. France
8.5.5. Rest of Europe

9. Asia Pacific Varicose Vein Treatment Devices (VVTD) Market Analysis, 2017-2027 (US$ Mn)
9.1. Overview
9.1.1. Asia Pacific VVTD Market Value and Growth, 2017-2027, (US$ Mn)
9.2. Asia Pacific VVTD Market Value, By Product Type, 2017-2027 (US$ Mn)
9.2.1. Market Analysis
9.3. Asia Pacific VVTD Market Value, By Treatment Type, 2017-2027 (US$ Mn)
9.3.1. Market Analysis
9.4. Asia Pacific VVTD Market Value, By End-user, 2017-2027 (US$ Mn)
9.4.1. Market Analysis
9.5. Asia Pacific VVTD Market Value, By Region/Country, 2017-2027 (US$ Mn)
9.5.1. Market Analysis
9.5.2. Japan
9.5.3. China
9.5.4. India
9.5.5. Rest of Asia Pacific

10. Rest of the World Varicose Vein Treatment Devices (VVTD) Market Analysis, 2017-2027 (US$ Mn)
10.1. Overview
10.1.1. Rest of the World VVTD Market Value and Growth, 2017-2027, (US$ Mn)
10.2. Rest of the World VVTD Market Value, By Product Type, 2017-2027 (US$ Mn)
10.2.1. Market Analysis
10.3. Rest of the World VVTD Market Value, By Treatment Type, 2017-2027 (US$ Mn)
10.3.1. Market Analysis
10.4. Rest of the World VVTD Market Value, By End-user, 2017-2027 (US$ Mn)
10.4.1. Market Analysis
10.5. Rest of the World VVTD Market Value, By Region, 2017-2027 (US$ Mn)
10.5.1. Market Analysis
10.5.2. Middle East & Africa
10.5.3. Latin America

11. Company Profiles
11.1. Medtronic plc
11.2. AngioDynamics, Inc.
11.3. biolitec AG
11.4. Syneron Medical Ltd.
11.5. Lumenis Ltd.
11.6. Dornier MedTech GmbH
11.7. Energist Group
11.8. Eufoton s.r.l.
11.9. Vascular Solutions, Inc.
11.10. Quanta System S.p.A.
11.11. Sciton, Inc.
11.12. Miravas
11.13. BTG plc
11.14. Sciton, Inc.
11.15. Merz Pharma GmbH & Co. KGaA
11.16. Fotona d.o.o.

List of Figures

FIG. 1 Global Varicose Vein Treatment Devices (VVTD) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global VVTD Market Segmentation
FIG. 4 Global VVTD Market, by Product Type, 2018 (US$ Mn)
FIG. 5 Global VVTD Market, by Treatment Type, 2018 (US$ Mn)
FIG. 6 Global VVTD Market, by End User, 2018 (US$ Mn)
FIG. 7 Global VVTD Market, by Geography, 2018 (US$ Mn)
FIG. 8 Attractive Investment Proposition, by Geography, 2087
FIG. 9 Global Market Positioning of Key VVTD Market Manufacturers, 2018
FIG. 10 Global VVTD Market Value Share, by Product Type, 2018 & 2027 (Value %)
FIG. 11 Global Ablation Devices Market, 2017–2027 (US$ Mn)
FIG. 12 Global Venous Closure Products Market, 2017–2027 (US$ Mn)
FIG. 13 Global Other Surgical Instruments Market, 2017–2027 (US$ Mn)
FIG. 14 Global VVTD Market Value Share, by Treatment Type, 2018 & 2027 (Value %)
FIG. 15 Global Endovenous Ablation (EVLA) Market, by Treatment Type, 2017–2027 (US$ Mn)
FIG. 16 Global Sclerotherapy Market, by Treatment Type, 2017–2027 (US$ Mn)
FIG. 17 Global Surgical Ligation & Stripping Market, by Treatment Type, 2017–2027 (US$ Mn)
FIG. 18 Global VVTD Market Value Share, by End User, 2018 & 2027 (Value %)
FIG. 19 Global Hospitals Market, 2017–2027 (US$ Mn)
FIG. 20 Global Specialty Clinics Market, 2017–2027 (US$ Mn)
FIG. 21 Global Ambulatory Surgical Centers Market, 2017–2027 (US$ Mn)
FIG. 22 North America VVTD Market, 2017–2027 (US$ Mn)
FIG. 23 Europe VVTD Market, 2017–2027 (US$ Mn)
FIG. 24 Asia Pacific VVTD Market, 2017–2027 (US$ Mn)
FIG. 25 RoW VVTD Market, 2017–2027 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Varicose Vein Treatment Devices (VVTD) Market
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Restraints
TABLE 4 Global VVTD Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 5 Global VVTD Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 6 Global VVTD Market, by End User, 2017–2027 (US$ Mn)
TABLE 7 Global VVTD Market, by Geography, 2017–2027 (US$ Mn)
TABLE 8 North America VVTD Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 9 North America VVTD Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 10 North America VVTD Market, by End User, 2017–2027 (US$ Mn)
TABLE 11 North America VVTD Market, by Country, 2017–2027 (US$ Mn)
TABLE 12 Europe VVTD Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 13 Europe VVTD Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 14 Europe VVTD Market, by End User, 2017–2027 (US$ Mn)
TABLE 15 Europe VVTD Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 16 Asia Pacific VVTD Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 17 Asia Pacific VVTD Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 18 Asia Pacific VVTD Market, by End User, 2017–2027 (US$ Mn)
TABLE 19 Asia Pacific VVTD Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 20 Rest of the World VVTD Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 21 Rest of the World VVTD Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 22 Rest of the World VVTD Market, by End User, 2017–2027 (US$ Mn)
TABLE 23 Rest of the World VVTD Market, by Region, 2017–2027 (US$ Mn)
TABLE 24 Medtronic plc: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 AngioDynamics, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 biolitec AG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Syneron Medical Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Lumenis Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Dornier MedTech GmbH: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Energist Group: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 Eufoton s.r.l.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 Vascular Solutions, Inc..: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 Quanta System S.p.A.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Sciton, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 35 Miravas: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 36 BTG plc: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 37 Sciton, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 38 Merz Pharma GmbH & Co. KGaA: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 39 Fotona d.o.o.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)